Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck

We aimed to evaluate the efficacy and safety of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). In total, 37 patients with stage III or IV SCCHN were enrolled on the study. The chemotherapy consisted...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, J G, Sohn, S K, Kim, D H, Baek, J H, Jeon, S B, Chae, Y S, Lee, K B, Park, J S, Sohn, J H, Kim, J C, Park, I K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361495/
https://www.ncbi.nlm.nih.gov/pubmed/16251869
http://dx.doi.org/10.1038/sj.bjc.6602849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361495/
https://www.ncbi.nlm.nih.gov/pubmed/16251869
http://dx.doi.org/10.1038/sj.bjc.6602849

Ejemplares similares